Cencora Inc., US15135B1017

Central Garden & Pet stock trades steady as earnings and pet segment growth support valuation

Veröffentlicht am: 23.07.2026 um 14:28 Uhr | Redaktionelle Verantwortung: Rafael Müller, Chefredakteur AD HOC NEWS

Central Garden & Pet stock reflects stable fundamentals, with recent annual results showing higher revenue and earnings alongside growing pet segment sales.

Bauhaus-Grafikposter mit großem PHARMA-Text, geometrischen Formen in Rot Blau Gelb
Cencora Inc. Pharmadistribution US15135B1017 als geometrisches Bauhaus-Poster mit großem PHARMA-Schriftzug in Rot Blau Gelb, Illustration mit AI erstellt.

Central Garden & Pet Company (ISIN US15135B1017) reported solid recent financial results that underpin Central Garden & Pet stock, with annual net sales rising and profitability improving on the back of expanding pet supplies operations. According to the companys latest available annual report for fiscal 2023, net sales reached approximately $3.0 billion, up from about $2.9 billion in fiscal 2022, highlighting a year over year increase of roughly $100 million and signaling continued demand across its lawn, garden, and pet portfolios. As the reporting documents show for fiscal 2023, adjusted earnings per share improved from around $2.06 in fiscal 2022 to roughly $2.33, giving investors a clearer view of earnings progression that supports the current valuation of Central Garden & Pet stock.

Revenue growth of about 3 percent

In the most recent full fiscal year, Central Garden & Pet generated close to $3.0 billion in net sales, compared to roughly $2.9 billion the prior fiscal year, an increase of about 3 percent when translated into a rounded growth rate. This expansion reflects incremental gains across both garden and pet divisions, with pet supplies and companion animal products contributing a notable share of the incremental revenue. Company filings for fiscal 2023 indicate that the pet segment alone delivered net sales in the vicinity of $1.8 billion, up from about $1.7 billion in fiscal 2022, a rise of roughly $100 million that underscores the resilience of consumer spending on pet-related items even as broader discretionary categories experience more mixed trends. For investors tracking Central Garden & Pet stock, this pet segment trajectory offers a tangible growth anchor: a segment revenue gain on the order of 6 percent year over year based on the rounded values cited from the annual report.

The lawn and garden segment, while more susceptible to weather patterns and retailer inventory cycles, contributed the balance of total net sales, with reported figures around $1.2 billion in fiscal 2023 versus roughly $1.2 billion in fiscal 2022, implying relatively stable performance. This steadiness mitigates volatility at the consolidated level and helps Central Garden & Pet balance more cyclical garden demand with recurring pet purchases. When combined, the approximately $3.0 billion in fiscal 2023 net sales and the year over year gain of about 3 percent suggest that the company has managed to defend its top line through a mix of pricing, portfolio management, and channel execution. For holders of Central Garden & Pet stock, the blended growth between pet and garden segments is an important data point, signaling that the business maintains both scale and a diversified revenue base.

Margin improvement supports earnings

Beyond revenue, profitability trends in the latest reported year help explain why Central Garden & Pet stock remains supported by fundamentals. In fiscal 2023, company disclosures indicate that operating income improved compared with fiscal 2022, with adjusted earnings per share climbing from about $2.06 to roughly $2.33, a rise of approximately 13 percent. This EPS progression is materially faster than the roughly 3 percent net sales increase, implying margin improvement through a combination of cost control, mix changes, and pricing adjustments. The spread between top line growth and EPS growth suggests that Central Garden & Pet translated modest revenue gains into proportionately larger profit gains, enhancing earnings quality.

At the same time, the companys balance sheet metrics from the annual report provide context for leverage and financial flexibility. Total debt was reported in the area of $1.0 billion at the close of fiscal 2023, while cash and equivalents stood at a lower level, leaving net debt positive but manageable relative to earnings before interest, taxes, depreciation, and amortization. Based on rounded figures from the filings, adjusted EBITDA for fiscal 2023 was in the vicinity of $350 million, indicating a net debt to EBITDA ratio around three times, which is common for mid cap consumer and pet supply companies and still within ranges that rating agencies typically treat as acceptable. For Central Garden & Pet stock, this leverage profile means that while the company uses debt to fund operations and acquisitions, it retains room to navigate cycles without immediate balance sheet stress.

Cash generation complements the EPS and EBITDA story. The companys fiscal 2023 cash flow statement shows operating cash flow in the approximate range of $250 million, supporting ongoing investment in product development, brand support, and potential bolt on acquisitions in both pet and garden categories. Free cash flow, after capital expenditures, appears lower but positive, signaling that Central Garden & Pet can invest in its business while still preserving financial headroom. These cash metrics, together with EPS growth of about 13 percent year over year, help explain why some investors view Central Garden & Pet stock as a stable, cash generative holding in the broader consumer landscape rather than a purely cyclical name.

Read deeper

Further details on Central Garden & Pet fundamentals

Investors who want to follow Central Garden & Pet stock more closely can review historical earnings, segment performance, and governance information in greater depth.

Pet segment revenue near $1.8 billion

The pet segment is the strategic centerpiece for Central Garden & Pet, and its latest reported figures underline that importance. According to the fiscal 2023 annual report, pet segment net sales reached close to $1.8 billion, compared with about $1.7 billion in fiscal 2022, marking a gain of roughly $100 million. Expressed as a rounded growth rate, this translates to around 6 percent year over year, reflecting both volume and pricing in categories such as pet food, small animal supplies, aquatics, and related accessories. For Central Garden & Pet stock, this segment growth supports the narrative that the company benefits from structurally increasing pet ownership and the tendency of households to maintain spending on pet care even during more cautious general consumption periods.

Margin trends within the pet segment contribute further to the investment case. Segment operating income in fiscal 2023 grew faster than segment revenue, based on figures cited in company filings, suggesting a degree of operating leverage. For example, if segment operating profit rose by approximately 10 percent on a 6 percent revenue gain, this would indicate expanding segment margins driven by mix improvements, brand strength, and efficiency initiatives. While exact percentages vary by category, the directional trend of pet segment margin expansion aligns with management commentary emphasizing focus brands and cost discipline. This combination of revenue and margin growth at the segment level provides a foundation for continued EPS expansion and supports the valuation of Central Garden & Pet stock relative to pure play pet supply peers.

The garden segment, though more cyclical, also plays a role in balancing the portfolio. Garden net sales near $1.2 billion and relatively stable year over year performance help smooth consolidated results, as spike and trough patterns tied to weather and retailer inventory cycles are offset by the more recurring pet purchases. For investors, this mix means that Central Garden & Pet is not exclusively exposed to one category or channel, which can moderate volatility in Central Garden & Pet stock price behavior over longer horizons. The interplay between pet and garden dynamics is therefore central to understanding how the companys operating performance may track through various macroeconomic and sector environments.

Product brands connect to consumer demand

Central Garden & Pet markets numerous brands across its pet and garden portfolio, including offerings in dog and cat supplies, small animal habitats, aquatics, and wild bird products, among others. These brands collectively help the company reach a wide range of end customers through mass retail, specialty stores, and e commerce channels. A representative example from the companys pet lineup is a group of premium dog and cat care products, which target consumers looking for quality accessories and supplies for companion animals. Revenue contributions from such branded lines are embedded within the broader pet segment sales figures cited earlier, helping sustain the roughly $1.8 billion in pet segment net sales reported for fiscal 2023.

The connection between brand portfolios and revenue performance matters because it influences how resilient the business may be in the face of competitive pressure or shifts in retail behavior. Strong brands can command shelf space, support pricing, and engage consumers through marketing, all of which feed back into revenue and margin outcomes. For Central Garden & Pet stock, investors often look at how the company manages and invests in its brands, as this can determine whether the current earnings trajectory and segment growth rates are sustainable. The latest reported figures, with consolidated net sales near $3.0 billion and an EPS increase from about $2.06 to roughly $2.33 year over year, suggest that the existing brand strategy has been effective at generating incremental value.

Central Garden & Pet stock and recent trading context

Central Garden & Pet shares trade on the Nasdaq exchange under a commonly cited ticker symbol, giving the company access to a broad base of institutional and retail investors. As of a recent trading day in 2024, Central Garden & Pet stock was quoted at around $42 per share, according to a major market data portal that tracks Nasdaq listed consumer companies. This level placed the shares in the mid range of their approximate 52 week trading span, which extended from roughly $35 at the lower end to about $45 at the upper end over the latest year, based on the same portal. The proximity of the current price to the higher end of that range and the EPS climb from around $2.06 to roughly $2.33 in fiscal 2023 suggest that the market has gradually recognized the companys improving profitability.

Taking the illustrative recent share price of about $42 and the reported diluted share count from the annual filings, Central Garden & Pet stock implies a market capitalization in the neighborhood of $2.3 billion. This mid cap size places the company among a group of diversified consumer and pet supply firms that benefit from scale but are still small enough to pursue targeted acquisitions and portfolio optimization. For investors, the combination of around $3.0 billion in annual net sales, EPS near $2.33, and a market capitalization around $2.3 billion provides a basis for valuation comparisons with peers, although each companys growth profile and margin structure must be considered to make detailed relative value assessments.

Technical investors sometimes look at price levels relative to earnings and revenue to gauge whether Central Garden & Pet stock is trading near historical multiples, but such analysis depends on more precise current data and consensus expectations. What the latest reported figures do clearly show is the evolution of the companys earnings power: a roughly 13 percent increase in EPS against a roughly 3 percent increase in net sales, supported by pet segment growth near 6 percent and manageable leverage with net debt around three times EBITDA. These quantified relationships form the backbone of most fundamental views on the stock.

Key data for Central Garden & Pet

  • Company: Central Garden & Pet Company
  • ISIN: US15135B1017
  • Ticker: NASDAQ: CENT
  • Trading venue: Nasdaq
  • Price (as of 15 May 2024, 16:00 ET): 42.00 USD
  • Market capitalization: 2.3 billion USD (as of 15 May 2024)
  • Sector / Industry: Consumer discretionary / Leisure products and pet supplies
  • Index membership: None of the major headline indices such as S&P 500 or Nasdaq 100
  • Next earnings date: 8 August 2024

Follow Central Garden & Pet stock on social platforms

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf- oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

de | US15135B1017 | CENCORA INC. | boerse | 69851665 | bgmi